Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Baricitinib is a promising treatment for alopecia areata.

Chronic ethanol increases certain brain receptor levels, influenced by steroids and protein changes.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Heat shock proteins help basal cell carcinoma grow by responding to inflammation signals.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Estrogen receptors affect hair growth, with ER beta slowing down the hair cycle changes caused by ER alpha.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Enzymes can release hydrocarbons from Botryococcus braunii without harming cells, suggesting potential for continuous extraction.

The new delivery system improved hair growth in alopecia treatment.

Lower SMAD2/3 activation predicts more severe skin cancer.

Baricitinib can cause excessive hair growth.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

Human hair follicles have a scent receptor that can influence hair growth.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.